
Alaunos Therapeutics Investor Relations Material
Latest events

Q1 2023
Alaunos Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Alaunos Therapeutics Inc
Access all reports
Alaunos Therapeutics Inc. is a clinical-stage biotechnology company focused on developing innovative cell therapies for cancer treatment. The company specializes in T-cell receptor (TCR) therapies, leveraging its proprietary Sleeping Beauty non-viral gene transfer platform to engineer T-cells that target solid tumors with specific genetic mutations. Alaunos’s pipeline targets a range of cancers, including lung, ovarian, and pancreatic cancers. The company is headquartered in Houston, Texas, and its shares are listed on the NASDAQ.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
TCRT
Country
🇺🇸 United States